What Teva-Losartan treats: Main Uses and Benefits

Teva-Losartan is a prescription treatment option primarily authorized for the management of essential hypertension (high blood pressure). It assists in achieving and maintaining blood pressure within an acceptable range, which may help reduce the possibility of serious associated cardiovascular outcomes, such as stroke and heart attack. The medication is also indicated for specific, supportive care needs.

For patients with high blood pressure and left ventricular hypertrophy (enlargement of the heart wall), Teva-Losartan is used to help manage the reduced possibility of stroke. Additionally, it is a supportive therapy for adults diagnosed with both Type 2 diabetes and hypertension who show signs of diabetic nephropathy (kidney disease), where it helps to slow the rate of worsening of the condition. For detailed information on authorized indications and patient guidance, consult with a healthcare professional or the product's official prescribing information.

---

Quick Fact: Therapeutic Support

Teva-Losartan is designed to provide therapeutic assistance for sustained blood pressure control and to offer a beneficial effect in managing specific cardiovascular and renal risks in approved patient groups.

Regulatory References

1. NIH MedlinePlus guidance on Losartan

Eligibility Scope

Populations for whom use is allowed (as stated in label):

• Adults (18 years and older) for all authorized indications.
• Pediatric patients 6 years of age and older for the treatment of hypertension.
• Patients with mild-to-moderate renal impairment (no initial dosage adjustment needed, unless volume-depleted).

Populations for whom use is contraindicated:

• Patients in the second and third trimesters of pregnancy due to risk of fetal harm.
• Patients with severe hepatic impairment (severe liver disease).
• Patients with diabetes who are concurrently taking products containing Aliskiren.
• Patients with known hypersensitivity to Losartan potassium or any component of the medicine.

Age-related eligibility rules:

• The medicine is not recommended in children under 6 years of age or in pediatric patients with a Glomerular Filtration Rate (GFR) less than 30 mL/min/1.73 m^2.
• Use in the elderly (over 75) does not usually require dose adjustment but is subject to caution.

Eligibility-related restrictions:

• The benefit of stroke risk reduction associated with Losartan may not apply to Black patients with hypertension and Left Ventricular Hypertrophy.
• Patients who are intravascularly volume-depleted must have the condition corrected before use, or a lower starting dose is required.

Pregnancy and lactation eligibility status:

• Contraindicated in the 2nd and 3rd trimesters; not recommended in the 1st trimester.
• Not recommended for breastfeeding women.

Connection to the overall eligibility profile

Official regulatory documents define the eligible population as adults and children ge 6 years old for hypertension, while establishing clear prohibitions based on life stage and comorbidity. These prohibitions classify use as contraindicated due to the risk of fetal harm, the severity of organ dysfunction (severe hepatic impairment), or absolute drug interaction risk (Aliskiren in diabetes). The structure distinguishes between authorized, conditionally restricted, and prohibited populations based strictly on regulatory classification.

Interactions with other medicines and products

Losartan potassium (Teva-Losartan) has officially documented interaction patterns primarily involving the Renin-Angiotensin System and metabolic pathways.

Restricted and Contraindicated Combinations

The co-administration of Losartan with Aliskiren is contraindicated in patients with Type 2 diabetes due to an increased risk of hypotension, hyperkalemia, and renal impairment. Dual inhibition of the Renin-Angiotensin System (RAS) agents, such as combining Losartan with ACE Inhibitors, is generally avoided. Agents that increase serum potassium, including potassium supplements, salt substitutes containing potassium, and potassium-sparing diuretics, increase the documented risk of hyperkalemia.

Pharmacodynamic and Metabolic Interactions

Concomitant use with NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) can increase the risk of renal impairment and may reduce Losartan's antihypertensive effect, particularly in volume-depleted patients. Losartan can reduce the renal clearance of Lithium, leading to increased serum Lithium concentrations and potential toxicity. Losartan undergoes metabolism via CYP450 enzymes. Fluconazole (a CYP2C9 inhibitor) is documented to increase the plasma exposure of Losartan. Conversely, Rifampin (a CYP inducer) is documented to reduce the exposure of both Losartan and its active metabolite. Losartan may be administered with or without food.

How Teva-Losartan Works

Losartan is a selective, competitive antagonist acting primarily within the Renin-Angiotensin System (RAS). Its mechanism is centered on the Angiotensin II Type 1 receptor (AT1), located in tissues such as vascular smooth muscle and the adrenal glands. Losartan binds to the AT1 receptor with high affinity, competitively blocking the natural ligand, Angiotensin II. This antagonism inhibits the AT1 receptor-mediated signaling sequence.

AT1 receptor activation typically initiates vasoconstriction and stimulates aldosterone release. By preventing this binding, Losartan functionally reverses these effects. The primary consequence is the inhibition of Angiotensin II-mediated contraction of vascular smooth muscle and a decrease in signaling for aldosterone synthesis and secretion. This molecular cascade results in a modulation of peripheral vascular resistance and a reduction in sodium and water reabsorption, altering systemic physiological parameters.

How to use Teva-Losartan

Teva-Losartan is authorized for oral administration only, available as a film-coated tablet in strengths of 25 mg, 50 mg, and 100 mg of losartan potassium. The tablets are designed to be swallowed whole with water and can be taken with or without food. To ensure consistent systemic drug levels, the medicine should be administered at about the same time each day.

---

Standard Administration Schedule

Instruction	Detail
Route of administration	Oral (tablet or prepared suspension).
Dosing schedule (Adults)	Usual starting dose is 50 mg once daily; maximum dose is 100 mg once daily.
Frequency pattern	Once daily (qDay) for all main indications.
Timing in relation to meals	May be taken with or without food.

---

Population-Specific Adjustments

Specific initial dose adjustments are required for certain clinical contexts:

• Intravascular Volume Depletion: A lower starting dose of 25 mg once daily is specified for patients who are at risk of volume depletion.
• Hepatic Impairment: The recommended initial dose for patients with mild-to-moderate liver impairment is 25 mg once daily.
• Pediatric Patients (6–16 years): The starting dose is determined by body weight, typically 0.7 mg/kg once daily (up to a 50 mg total dose). Losartan is not recommended for pediatric patients under six years of age.

The antihypertensive effect typically reaches its maximum benefit three to six weeks following the initiation of treatment. If a dose is missed, it should be taken as soon as possible, but double doses should be avoided to compensate for the missed one.

Research evidence / Overview of studies for Teva-Losartan

Evidence for Use in Managing Essential Hypertension

Research has focused extensively on how losartan potassium, the active ingredient in Teva-Losartan, was studied for its role in the study of high blood pressure, known as essential hypertension. The primary research base includes Randomized Controlled Trials (RCTs) that research examined changes in systolic and diastolic blood pressure (BP). Long-term studies monitored participants to track the overall incidence of major CV events such as stroke and heart attack.

Findings describe patterns observed in the studies consistent with patterns observed across similar research. When was compared to a placebo, losartan was associated with measured changes in blood pressure. Findings indicate that the magnitude of measured BP reduction may differ across various ethnic groups, a pattern that was observed in some studies of this class of blood pressure medicines.

---

Evidence for Use in Hypertension with Left Ventricular Hypertrophy (LVH)

The evidence base for losartan's evaluation in patients with high blood pressure and Left Ventricular Hypertrophy (LVH) comes from large, long-term randomized outcome trials. These studies monitored older adults with LVH to measure the occurrence of major events, specifically tracking cardiovascular death, myocardial infarction, and stroke. The research examined whether losartan was associated with measured differences in event rates when compared to an alternative blood pressure medication.

In these large trials, findings indicate that when compared to the control drug, losartan was associated with fewer strokes in the overall non-Black study population. Research documentation indicates that the observed pattern of stroke outcome in the primary trial was not observed in Black patients with hypertension and LVH, meaning the evidence is limited for this specific population.

---

What Remains Unclear and Areas for Future Research

Although a large amount of research exists, some areas remain uncertain. For instance, in studies related to diabetic nephropathy, the primary analysis relied on surrogate endpoints (like doubling of serum creatinine); certainty remains low for conclusions based solely on these surrogate markers. Additionally, data for certain groups remain insufficient, particularly concerning the long-term outcomes for pediatric patients (children and adolescents).

Common questions about Teva-Losartan (FAQ)

Q: What is the difference between Teva-Losartan and regular Losartan?

A: Teva-Losartan is classified as a generic version of the drug Losartan. Regulatory agencies require generic medicines to contain the same active ingredient (Losartan potassium) and demonstrate that they work the same way in the body as the original product. Any differences between Teva-Losartan and the brand-name product typically exist only in the inactive ingredients used in the tablet.

Q: Does Teva-Losartan make you tired or dizzy?

A: Official regulatory documents list dizziness as a common side effect that may affect up to 1 in 10 people. While general tiredness (fatigue) is not always listed in the common side effect category, some documents report it as a possible non-serious adverse reaction. If dizziness is experienced, the official guidance suggests exercising caution.

Q: Can you drink coffee or caffeine while taking Teva-Losartan?

A: Official regulatory information does not list caffeine or coffee as a direct interaction with Losartan. However, since caffeine is a stimulant that can temporarily affect blood pressure, the product information does not recommend specific limits for caffeine intake, but individuals may discuss their caffeine consumption with a healthcare provider.

Q: Can Teva-Losartan damage the kidneys over time?

A: Losartan is authorized for use in patients with diabetic kidney disease to reduce specific risks. However, regulatory documents state that in certain susceptible patients (such as those with heart failure), use may be associated with changes in renal function (kidney function). For this reason, official guidance specifies that close monitoring by a healthcare provider is necessary for these patients.

Q: What if I miss a dose of Teva-Losartan?

A: Official patient guidance states that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for your next scheduled dose, the missed dose should be skipped entirely. Official regulatory documents state that double doses should not be used to compensate for a missed one.

Q: Is there a risk of hair loss with Teva-Losartan?

A: Official regulatory safety profiles, which categorize documented side effects by frequency, do not list hair loss (alopecia) among the common or rare adverse reactions. This suggests that the occurrence of this effect is very low or has not been established in clinical trials or post-marketing surveillance.

Q: Does Teva-Losartan cause weight gain or weight loss?

A: The official regulatory documents outlining the adverse reactions reported during clinical trials do not list weight gain or weight loss among the common or rare side effects associated with Losartan potassium.

Q: How is Teva-Losartan different from Lisinopril?

A: Losartan belongs to the class of medicines called Angiotensin II Receptor Blockers (ARBs), while Lisinopril belongs to a separate class known as Angiotensin-Converting Enzyme (ACE) Inhibitors. Although both classes are used to treat high blood pressure, they work by blocking different molecular steps within the Renin-Angiotensin System.

Q: Can Teva-Losartan be used for conditions other than high blood pressure?

A: Yes, regulatory agencies have authorized Losartan potassium for multiple uses, not just high blood pressure (hypertension). It is also authorized to reduce the risk of stroke in patients with hypertension and Left Ventricular Hypertrophy, and for the treatment of diabetic nephropathy (kidney disease) in patients with Type 2 diabetes.

Q: Does Teva-Losartan interact with pain relievers like Ibuprofen?

A: Official product information documents a potential interaction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as Ibuprofen. This combination is documented to potentially reduce the blood pressure lowering effect of Losartan and increase the risk of kidney function impairment, particularly in susceptible patients.

Q: Will Teva-Losartan interfere with my birth control pills?

A: Official drug interaction documentation, which is based on clinical and regulatory data, do not list a known interaction between Losartan potassium and common oral contraceptives (birth control pills).

Q: Is Teva-Losartan safe to take with supplements like magnesium or iron?

A: Regulatory documents specifically warn against the co-administration of Losartan with potassium supplements and potassium-containing salt substitutes due to the risk of high potassium levels (hyperkalemia). Other common supplements, such as magnesium and iron, are not typically listed in the documented interaction profiles.

Q: Is it possible to have an interaction with herbal remedies while on Teva-Losartan?

A: Official regulatory patient information universally advises individuals to inform their healthcare provider of all products they are taking. This includes any herbal products or traditional remedies, as these products may contain ingredients that can affect blood pressure or interact with prescription medicines.

Q: Does the brand name Teva make a difference compared to others?

A: Teva-Losartan is a generic product. Regulatory agencies, like the FDA, require all generic drugs to meet strict standards for quality and purity. They must also demonstrate bioequivalence, meaning they are expected to work in the body in the same way as any other generic or brand-name product containing Losartan potassium.

Q: Does Teva-Losartan interact with cold and flu medicines?

A: Some cold and flu medicines contain ingredients such as decongestants (sympathomimetics) which can potentially raise blood pressure or interfere with Losartan's antihypertensive effect. Official documents advise caution or avoidance of such combinations due to potential cardiovascular effects.

Q: Can taking Teva-Losartan make my blood sugar levels change?

A: Losartan potassium is authorized for use in patients with Type 2 diabetes and kidney disease. Some clinical studies have examined Losartan's effect on glucose metabolism and insulin sensitivity. Patients with diabetes are routinely monitored for changes in blood sugar levels while on any blood pressure medicine.

Q: Does taking Teva-Losartan affect my driving ability?

A: Official regulatory information states that Losartan is unlikely to affect the ability to drive or use machines. However, because it is a blood pressure medicine, it can cause dizziness or drowsiness in some people. Official guidance cautions against driving or operating machinery if dizziness or drowsiness is experienced.

Q: What if Teva-Losartan causes stomach upset or nausea?

A: Regulatory documentation classifies adverse reactions by the affected system, including Gastrointestinal Disorders. While not always listed as a common effect, non-serious gastrointestinal effects like stomach upset or nausea are sometimes reported as possible side effects.

Q: How often do I need blood tests while taking Teva-Losartan?

A: Losartan can affect serum potassium levels and renal function (kidney function). Official regulatory guidance recommends that these be assessed or monitored by a healthcare provider, typically 2 to 4 weeks after starting the medication or following a dose adjustment.

Q: What is the process for Teva-Losartan disposal if I have unused tablets?

A: Unused or expired Losartan should be disposed of in accordance with federal, state, and local regulations. Patients can use a local Drug Take-Back Program or follow the official FDA guidance for safely disposing of unused medicines at home.

Q: Does Teva-Losartan interact with medication for anxiety or depression?

A: The official interaction profiles for Losartan primarily document risks related to the Renin-Angiotensin System, potassium levels, and certain metabolic pathways. The label does not list a specific general interaction with the broad class of anti-anxiety or depression medicines.

Q: Is it normal to feel lightheaded when standing up on Teva-Losartan?

A: As a medicine that lowers blood pressure, Losartan can sometimes cause a feeling of dizziness or lightheadedness, particularly when moving quickly from a sitting or lying position to a standing position. Dizziness is listed as a common side effect in the product’s safety information.

Q: Does Teva-Losartan affect sexual function?

A: Sexual dysfunction is a recognized potential issue with some medicines used to treat high blood pressure. Clinical studies have examined Losartan’s effects on sexual function, indicating that it may be a less common concern than with some other classes of antihypertensive drugs.

Q: Can Teva-Losartan cause swelling in the ankles or feet?

A: Swelling of the ankles or feet (edema) is not listed among the common or rare side effects in the official regulatory documentation. However, a severe and rare side effect called Angioedema (swelling of the face, lips, or throat) is documented.

Q: What does it mean if the Teva-Losartan tablet is scored?

A: If the tablet is scored (it has a line across its surface), this physical characteristic is documented to indicate that the tablet is designed to be divided into equal halves. This allows for dose adjustment if a healthcare provider directs you to take half a tablet.

Official Storage and Disposal Requirements

Teva-Losartan (Losartan Potassium) tablets must be stored in accordance with official regulatory requirements to ensure product integrity and safety.

Storage Conditions

The tablets require storage at Controlled Room Temperature, which ranges from 20 C to 25 C (68 F to 77 F). The product must be kept in its original container and protected from excessive moisture and light. It is a mandatory requirement to store Losartan Potassium tablets out of the sight and reach of children.

Compounded Suspension

If the oral suspension is prepared by a healthcare professional, it must be stored under refrigeration (2 C to 8 C) and is stable for a maximum of four weeks.

Disposal

Unused or expired Teva-Losartan must be disposed of following all applicable federal, state, and local regulations.